
Kyndryl upgraded to buy with 19% upside as profitability and cash flow improve.
Kyndryl has been upgraded to a buy rating with a price target of $13, implying a 19% potential upside. The company is undergoing a transformation aiming for 80% of its revenue to come from higher-margin post-spin signings by fiscal year 2027. Recent ...

